A 72-year-old lady was admitted to hospital with a large, bleeding mass on the right groin and an 8-month history of deep vein thrombosis of the left leg with pulmonary microembolisation treated medically. On clinical examination there was a solid, necrotising and bleeding right inguinal mass which extended 20 cm below the right inguinal ligament. A tissue biopsy, performed under local anaesthesia, revealed the presence of a non Hodgkin lymphoma with giant B-cells of follicular origin. An angio-CT scan of the pelvis and of the leg showed the compression of the 30 cm diameter tumour on the surrounding tissues. The mass appeared to be extra-compartmental and to have a non-homogeneous aspect with internal areas of necrosis and colliquation. Particular attention was devoted to the femoral vessels which were apparently not involved in the tumour mass. The patient was then operated on by a team of vascular and plastic-reconstructive surgeons. She underwent an operation consisting in an inguinal mass excision and skeletisation of the femoral vessels and nerve. The wound was then closed using both an abdominal and lateral flap from the hip. Postoperatively the patient made an uneventful recovery and was discharged from hospital on postoperative day 11. Follow-up at 3 months showed good healing of the wound and no signs of metastatic spread of the tumour.

Download full-text PDF

Source

Publication Analysis

Top Keywords

hodgkin lymphoma
8
inguinal mass
8
femoral vessels
8
mass
5
giant hodgkin
4
lymphoma scarpa's
4
scarpa's triangle
4
triangle case
4
case report
4
report 72-year-old
4

Similar Publications

Purpose: More active high-dose chemotherapy (HDC) regimens are needed for autologous stem-cell transplantation (ASCT) for refractory lymphomas. Seeking HDC enhancement with a poly(ADP-ribose) polymerase (PARP) inhibitor, we observed marked synergy between olaparib and vorinostat/gemcitabine/busulfan/melphalan (GemBuMel) against lymphoma cell lines, mediated by inhibition of DNA damage repair. Our preclinical work led us to clinically study olaparib/vorinostat/GemBuMel with ASCT.

View Article and Find Full Text PDF

This review discusses multiple aspects of follicular lymphoma (FL), including etiology, treatment challenges, and future perspectives. First, we delve into the etiology of FL, which involves a variety of pathogenic mechanisms such as gene mutations, chromosomal abnormalities, immune escape, immune system dysregulation, familial inheritance, and environmental factors. These mechanisms provide the context for understanding the diversity and complexity of FL.

View Article and Find Full Text PDF

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL) in adults, constituting a significant portion of global incidence rates. DLBCL can be further classified via genetic expression profiling into molecular subsets consisting of not-otherwise specified (NOS) subset being the most prevalent, germinal center B-cell-like (GCB) subset, and activated B-cell-like (ABC) subset. The ABC subset, marked by abnormal NF-κB signaling, is associated with poorer outcomes.

View Article and Find Full Text PDF

Background: Few studies have investigated associations between per- and polyfluoroalkyl substances (PFAS) and childhood cancers. Detectable levels of PFAS in California water districts were reported in the Third Unregulated Contaminant Monitoring Rule for 2013-2015.

Methods: Geocoded residences at birth were linked to corresponding water district boundaries for 10,220 California-born children (aged 0-15 years) diagnosed with cancers (2000-2015) and 29,974 healthy controls.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!